Clinical Observation of Rabeprazole Joint Mosapride will the Treatment of the Reflux esophagitis

Objective Efficacy and safety of Rabeprazole joint Mosapride treatment of the reflux esophagitis(RE).Methods By gastroscope confirmed the reflux esophagitis 110 cases were randomly divided into patients 55 treatment group and control group.Treatment group: oral Rabeprazole 10mg evening meal times,Mosapride will take time,three times a day,5mg,half an hour before meal.Control group: Prilosec 20mg/d,before dinner,Mosapride will take a method.Two groups of patients were treated for six weeks to finish,the clinical curative effect and safety of clinical observation.Results Two group total effectiveness(clinical symptoms and clinical symptoms improved under the upper) alleviating mucosal lesions respectively 94.54% treatment group(52/55),76.36% control group(42/55),the total effective rate in treatment group than in control group(P0.05),and the adverse reactions.Conclusion Rabeprazole joint Mosapride treat of the reflux esophagitis clinical symptoms improved rapidly,clinically superior to control group,and safe and reliable.